Zdrowie i gospodarka · 03/04/2000

FDA Announces Guidance on Street Drug Alternatives

The Food and Drug Administration (FDA) has made available a guidance document informing industry and the public that products marketed as street drug alternatives are considered unapproved new drugs and misbranded, potentially leading to regulatory action.